| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 412 | 1.056 | 265 | 0 | 2.307 |
| Total Income - EUR | - | - | - | - | - | 755 | 1.091 | 668 | 264 | 2.352 |
| Total Expenses - EUR | - | - | - | - | - | 12.152 | 22.506 | 4.246 | 15.305 | 5.544 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -11.398 | -21.414 | -3.579 | -15.041 | -3.192 |
| Net Profit/Loss - EUR | - | - | - | - | - | -11.420 | -21.446 | -3.586 | -15.041 | -3.192 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Panacea Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 14.481 | 7.186 | 6.688 | 7.054 | 14.747 |
| Inventories | - | - | - | - | - | 3.778 | 6.607 | 6.465 | 6.445 | 8.840 |
| Receivables | - | - | - | - | - | 0 | 171 | 172 | 171 | 4.880 |
| Cash | - | - | - | - | - | 10.703 | 409 | 52 | 437 | 1.027 |
| Shareholders Funds | - | - | - | - | - | -11.214 | -32.411 | -36.098 | -51.029 | -53.936 |
| Social Capital | - | - | - | - | - | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | 25.905 | 39.598 | 42.786 | 58.083 | 68.897 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4639 - 4639" | |||||||||
| CAEN Financial Year |
4639
|
|||||||||
Comments - Panacea Bio S.r.l.